72.1 F
San Diego
Monday, Jul 22, 2024
-Advertisement-

Abide Therapeutics Appoints Chief Financial and Strategy Officer

San Diego-based drug developer Abide Therapeutics has hired Sapna Srivastava as its chief financial and strategy officer.

Srivastava was most recently chief financial and strategy officer at the Massachusetts gene editing biotech Intellia Therapeutics. There, she played a key role in the Norvartis-backed company’s $108 million IPO in May of 2016.

Srivastava has more than 15 years of experience as a senior executive in the biopharmaceutical industry and on Wall Street.

Prior to her time at Intellia, Srivastava was a senior biotechnology analyst for Goldman Sachs, Morgan Stanley and ThinkEquity Partners LLC.

Srivastava has also served as an advisor for biotechnology companies and co-founded a biotech company focused on neuroscience. She began her career as a research associate at JP Morgan.

She graduated from St. Xavier’s College at the University of Mumbai and earned a doctoral degree in neuroscience from New York University.

Abide has offices in San Diego and in Princeton, New Jersey.

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-